News Releases

BMO Capital Markets to Host 8th Annual Focus On Healthcare Conference

NEW YORK, July 30, 2008 – BMO Capital Markets, the investment and corporate banking arm of BMO Financial Group (TSX, NYSE: BMO), will hold its eighth annual two-day conference, Focus On Healthcare, Tuesday, August 5 and Wednesday, August 6, at the Millennium Broadway Hotel in New York City.

Hosted by members of the BMO Capital Markets Healthcare Equity Research Team including Erik Chiprich, Christine Charette, Robert Hazlett, Dave Shove, Joanne Wuensch and Jason Zhang, this event features a unique mix of presentations by senior executives from more than 75 leading and emerging public and private companies focused on the following sectors:

Biotechnology
Health-care Facilities
Managed Care
Medical Technology & Devices
Pharmacy Benefit Managers
Pharmaceuticals & Specialty/Emerging Pharmaceuticals

Keynote address – August 5 – Dr. Peter R. Orszag
Dr. Orszag is the director of the Congressional Budget Office. He will discuss themes relating to options for slowing the growth of health care costs.

The complete conference agenda and presentations will be available:

www.bmocm.com/conferences/2008healthcare

Media interested in attending the conference and/or scheduling an interview should call (416) 867-3996 or toll free at 1-866-298-8385.

Participating companies include*:

Aastrom Biosciences (ASTM)
� terna Zentaris (AEZS)
Affymax (AFFY)
Allos Therapeutics (ALTH)
Archemix (private)
ArQule (ARQL)
AVI BioPharma (AVII)
Bio-Imaging Technologies (BITI)
BioMS Medical (MS)
Bionovo (BNVI)
Celgene (CELG)
Cougar Biotechnology (CGRB)
Emergent BioSolutions (EBS)
Idenix Pharmaceuticals (IDIX)
Idera Pharmaceuticals (IDRA)
InterMune (ITMN)
Medivation (MDVN)
MethylGene (MYLGF.PK)
Myriad Genetics (MYGN)
Optimer Pharmaceuticals (OPTR)
Paratek Pharmaceuticals (private)
Pharmacopeia (PCOP)
Poniard Pharmaceuticals (PARD)
Progenics Pharmaceuticals (PGNX)
QLT (QLTI)
Reata Pharmaceuticals (private)
Regeneron Pharmaceuticals (REGN)
Sangamo Biosciences (SGMO)
SuperGen (SUPG)
TransMolecular (private)
Tranzyme Pharma (private)
Vertex Pharmaceuticals (VRTX)
Ascend Health (private)
DSI (private)
Encompass Home Health (private)
Health Management Associates (HMA)
LCA-Vision (LCAV)
Medical Facilities (DR_UN.TO)
Northstar Healthcare (NHC)
NovaMed (NOVA)
TLCVision (TLCV)
Universal Health Services (UHS)
US Physical Therapy (USPH)
American CareSource Holdings (XSI)
BioScrip (BIOS)
Centene (CNC)
Cigna (CI)
CorVel (CRVL)
Humana (HUM)
Hythiam (HYTM)
Medco Health Solutions, Inc. (MHS)
The Parker Group (private)
Wellpoint (WLP)
Advanced Medical Optics (EYE)
AtriCure (ATRC)
BioSphere Medical, Inc. (BSMD)
C.R. Bard (BCR)
Cardiva Medical (Private)
Covidien (COV)
CyroCath (CRT.TO)
ESTECH (private)
Greatbatch (GB)
Integra LifeSciences (IART)
MIV Therapeutics (MIVI.OB)
Paragon Medical (Private)
Response Biomedical (RBM.TO)
STAAR Surgical Company (STAA)
Stryker (SYK)
The Cooper Companies (COO)
Vision-Sciences (VSCI)
VNUS Medical Technologies (VNUS)
Antares Pharma (AIS)
Clinical Data (CLDA)
Cortex Pharmaceuticals (COR)
Eli Lilly & Company (LLY)
Enzon Pharmaceuticals, Inc. (ENZN)
Intra-Cellular Therapies (private)
Ironwood Pharmaceuticals (Private)
King Pharmaceuticals (KG)
MacroGenics (Private)
MDRNA (MRNA)
Nektar Therapeutics (NKTR)
Oscient Pharmaceuticals, Inc. (OSCI)
Penwest Pharmaceuticals (PPCO)
Pozen (POZN)
Questcor Pharmaceuticals, Inc. (QSC)
Repligen (RGEN)
Salix Pharmaceuticals (SLXP)
Sepracor (SEPR)
Vitae Pharmaceuticals (Private)

*Agenda and participant list subject to change.

About the BMO Capital Markets Healthcare Equity Research Team
The BMO Capital Markets Healthcare Equity Research Team provides coverage of healthcare services, medical technology, specialty and large-cap pharmaceuticals, and biotechnology companies. The team includes: Christine Charette (Biotechnology, Canada); Erik Chiprich (Healthcare Facilities); Robert Hazlett (Pharmaceuticals); Dave Shove (Managed Care and Benefits); Joanne Wuensch (Medical Technology); and Jason Zhang (Biotechnology, U.S.).

About BMO Capital Markets
BMO Capital Markets is a leading full-service North American financial services provider, with 2,400 employees operating in 14 North American offices and 26 worldwide, offering corporate, institutional and government clients access to a complete range of investment and corporate banking products and services. BMO Capital Markets is a member of BMO Financial Group (NYSE, TSX: BMO), one of the largest diversified financial services providers in North America with total assets of US $377 billion and more than 36,000 employees as at April 30, 2008.

- 30 -

For further information: